Description | Enrichment ratio | p value | FDR | Genes |
---|---|---|---|---|
cAMP signaling pathway | 5.7451 | 2.1 × 10−5 | 6.7 × 10−3 | ACOX3; CACNA1C; CNGA3; GHSR; GRIA2; GRIN2D; HTR1E; PDE4C; RYR2 |
Neuroactive ligand-receptor interaction | 4.2918 | 2.0 × 10−4 | 3.2 × 10−2 | AVPR1A; CRHR1; GHSR; GRIA2; GRIN2D; HTR1E; LEP; PRLHR; PTGFR |
Circadian entrainment | 6.4865 | 9.6 × 10−4 | 0.104 | CACNA1C; CACNA1G; GRIA2; GRIN2D; RYR2 |
Cardiac muscle contraction | 7.0969 | 2.3 × 10−3 | 0.151 | CACNA1C; CACNG7; COX5A; RYR2 |
Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 6.9941 | 2.4 × 10−3 | 0.151 | ACTN2; CACNA1C; CACNG7; RYR2 |
Calcium signaling pathway | 4.2087 | 2.8 × 10−3 | 0.151 | AVPR1A; CACNA1C; CACNA1G; GRIN2D; PTGFR; RYR2 |
GABAergic synapse | 5.8144 | 4.8 × 10−3 | 0.220 | ABAT; CACNA1C; GAD1; SLC12A5 |
Type II diabetes mellitus | 8.226 | 5.6 × 10−3 | 0.226 | CACNA1C; CACNA1G; IRS2 |
Amyotrophic lateral sclerosis (ALS) | 7.0969 | 8.4 × 10−3 | 0.303 | GRIA2; GRIN2D; NEFM |
Alcoholism | 3.7009 | 1.1 × 10−2 | 0.350 | GRIN2D; H2AFY; HIST1H2AI; HIST1H2BK; HIST1H4I |